Clinical trial
Fat Tolerance From Lipid Emulsion Infusion Packaged in Glass or Plastic
NCT00278928 · Beth Israel Deaconess Medical Center, Other · Terminated
Key facts
| NCT number | NCT00278928 |
|---|---|
| Title | Fat Tolerance From Lipid Emulsion Infusion Packaged in Glass or Plastic |
| Official title | Prospective, Randomized Study of Fat Tolerance From Lipid Emulsion Infusion Packaged in Glass or Plastic Containers. |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Hypertriglyceridemia |
| Intervention type | Drug |
| Interventions | Liposyn III 20% (lipid infusion), Intralipid 20% (lipid infusion) |
| Enrollment | 82 |
| Start date | Jan 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | Jan 19, 2006 |
| Last update posted | Mar 14, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: